Vanguard Fiduciary Trust
LSTA icon

Vanguard Fiduciary Trust’s Lisata Therapeutics LSTA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
48,964
+14,047
+40% +$50K ﹤0.01% 3627
2026
Q1 		$175K Buy
+34,917
New +$144K ﹤0.01% 3555

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.8% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.14% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's LSTA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Lisata Therapeutics (LSTA) stake by 40% in Q2 2026, buying an estimated $50K and bringing the position to 48,964 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #3627.

Vanguard Fiduciary Trust first reported a position in LSTA in Q1 2026 and has held it in 2 quarters since. The position peaked at $175K in Q1 2026. 30 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Vanguard Fiduciary Trust held 48,964 shares of Lisata Therapeutics worth $166K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 14,047 Lisata Therapeutics shares in Q2 2026, an estimated $50K.
  • Lisata Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3627 holding.
  • Vanguard Fiduciary Trust first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Lisata Therapeutics position peaked at $175K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.